Yes, great share! I note it is now on the website...

Yes, great share!

I note it is now on the website https://medibio.com.au/company-news/ dated today.

I also note they have just listed the following jobs on Linkedin;
- Principle Software Engineer, Platform
- Project Manager
- Software Engineer, Mobile
- Product Marketing Manager

With Senior PR Manager still showing.

In respect to cash flow (from operating activities), ill leave this here for discussion;

Q4FY17
R&D (1,070,000)
Marketing (28,000)
Staffing (774,000)
Admin & Corp (602,000)

Q1FY18
R&D (1,116,000)
Marketing (35,000)
Staffing (587,000)
Admin & Corp (606,000)

Q2FY18
R&D (1,986,000)
Marketing (374,000)
Staffing (1,257,000)
Admin & Corp (1,319,000)

Q3FY18 (Budgeted)
R&D (2,300,000)
Marketing (300,000)
Staffing (1,500,000)
Admin & Corp (800,000)

Material inflows for this calendar year includes R&D rebate which will be closer to $4M, any share options to be exercised, VC revenue.

Outflows (at this stage)to be VC acquisition.

I have no issue raising cash, it's just raising cash with SP sub $0.40c.

@13th I don't think we will see any revenue from VA pre-FDA, Otsuka deal, on the other hand, might be a different story.

Looking forward to management buying on market, hopefully once quarterly is released!

Cheers
Mr.G